Gene Therapy for Cancer / Edition 1

Paperback (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $220.00
Usually ships in 1-2 business days
(Save 26%)
Other sellers (Paperback)
  • All (1) from $220.00   
  • New (1) from $220.00   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$220.00
Seller since 2007

Feedback rating:

(23585)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
BRAND NEW

Ships from: Avenel, NJ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer. Finally, in Part III, experts discuss the difficulties inherent in bringing gene therapy treatment for cancer to the clinic. This book will prove valuable as the volume of preclinical and clinical data continues to increase.

Read More Show Less

Editorial Reviews

From the Publisher
From the reviews:

"The book is divided into 3 sections. … this book is informative and provides a comprehensive review of the advances and limitations of cancer gene therapy. … Overall, the book provides enjoyable and instructive reading material. I highly recommend this book to scientists as well as clinicians as a reference source for cancer gene therapy. Readers would benefit from this excellent reading material, whether they are relatively new to this subspecialty or are actively working within the field of cancer gene therapy." (Prem Seth, JAMA, Vol. 299 (11), 2008)

"Gene Therapy for Cancer … covers the current technologies of cancer gene therapy as well as the difficult task of applying these in clinical trials. … The book also benefits through its helpful tables, drawings and illustrations. … Gene Therapy for Cancer provides a good overview of currently available techniques for cancer gene therapy and their limitations and potential for clinical applications. The book is a useful addition to the library of both researchers and clinicians working in the field." (S. Schepelmann and C. J. Springer, British Journal of Cancer, Vol. 98 (3), 2008)

“This new volume in Humana’s series is written for oncologists, hematologists, cancer researchers, geneticists.” (Tumori, Vol. 93, 2007)

Read More Show Less

Product Details

  • ISBN-13: 9781617375903
  • Publisher: Springer-Verlag New York, LLC
  • Publication date: 12/9/2010
  • Series: Cancer Drug Discovery and Development Series
  • Edition description: Softcover reprint of hardcover 1st ed. 2007
  • Edition number: 1
  • Pages: 469
  • Product dimensions: 0.97 (w) x 10.00 (h) x 7.00 (d)

Table of Contents

Table of Contents

CANCER GENE THERAPY

Introduction

- Kelly K. Hunt, M.D. and Stephan A. Vorburger, M.D., M.C.R.

Vectors

1. Adenovector-mediated Cancer Gene Therapy

- Bingliang Fang, M.D., Ph.D. and Jack A. Roth, M.D.

2. Efficacy, Toxicity and Immunogenicity of Adenoviral vectors

- Dmitry Shayakhmetov, Ph.D.

3. Lentiviral and Retroviral Vector Systems

- Renata Stripecke and Noriyuki Kasahara, M.D., Ph.D.

4. Vaccinia and Pox-Virus

- Sricharan Chalikonda, M.D. and David L. Bartlett, M.D.

5. Spinning Straw into Gold: The Potential of Replicating Herpes Simplex Virus as a Therapy for Cancer revealed by Genetic Alchemy

- Ian J. Mohr, Ph.D.

6. Alphavirus Vectors for Gene Therapy Applications

- Kenneth Lundstrom, Ph.D.

7. Vesicular Stomatitis Virus and RNA Viruses as Gene Therapy Vectors

- Glen N. Barber, Ph.D.

8. Parvovirus Vectors

- Selvarangan Ponnazhagan, Ph.D.

9. Non-Viral Vector Systems

- Pui-yan Lee and Leaf Huang, Ph.D.

Gene Therapy Approaches

10. Oncogenes, Tumor Suppressor Genes, and Apoptosis-Inducing Genes Utilized in Cancer Gene Therapy

- Lidong Zhang and Bingliang Fang, M.D., Ph.D.

11. Gene Silencing Therapy against Cancer

- Chao-Zhong Song, M.D., Ph.D.

12. Tumor Targeting-Retargeted Adenovirus

- Masato Yamamoto, M.D., Ph.D. and David T. Curiel, M.D., Ph.D.

13. Herpes Simplex Mediated Gene Therapy: Preclinical and and Clinical Approaches

- Richard H. Pin, Maura Reinblatt, Yuman Fong, and William R. Jarnagin, M.D.

14. Cytokine Gene Therapy for Genitourinary Cancer

- Terry L. Timme, Tetsuo Fujita, Hongyu Wang, Koji Naruishi, Dov Kadmon, Robert J. Amato, Brian J. Miles, Gustavo Ayala, Thomas M. Wheeler, Bin S. Teh, E. Brian Butler and Timothy C. Thompson, Ph.D.

15. Combination of Gene Therapy with Radiation

- Anupama Munshi, Ph.D. and Raymond E. Meyn, Ph.D.

16. Gene Transfer into Hematopoietic Stem Cells for Chemoprotection and in vivo Selection

- Justin C. Roth and Stanton L. Gerson, M.D.

17. Non-Viral Genetic Vaccines for Cancer

- Steven R. Little, Daniel G. Anderson Ph.D., and Robert Langer, Sc.D.

18. Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment

- Anita T. Tandle, Ph.D. and Steven K. Libutti, M.D.

19. Tumor-Specific Replicating Adenoviruses: Delta 24 for Human Gliomas

- Giacomo G. Vecil, M.D., Juan Fueyo, M.D., and Frederick F. Lang, M.D.

Clinical Applications

20. Problems, Side Effects and Disappointments in Clinical Cancer Gene Therapy

- Ta-Chiang Liu and David H. Kirn, M.D.

21. Trials and Tribulations in Developing Clinical Trials of Gene Therapy: E1A for Breast or Ovarian Cancer

- Naoto Ueno, M.D., Ph.D., Judith K. Wolf, M.D., David M. Gershenson, M.D., Gabriel N. Hortobagyi, M.D., and Mien-Chie Hung, Ph.D.

22. Phase I Clinical Experience with Intravenous Administration of PV701, an Oncolytic Virus

- Andrew L. Pecora, M.D. and Robert M. Lorence

23. MDA-7/IL-24 as a Multi-Modality Therapy for Cancer

- Sunil Chada, Ph.D., Dora Bocangel, Abujiang Pataer, Abner M. Mhashilkar, Satoshi Inoue, Ryo Miyahara, Jack A. Roth, Elizabeth A. Grimm, Stephen G. Swisher, M.D., Kelly K. Hunt, M.D. and Rajagopal Ramesh, Ph.D.

24. Development of Therapeutic Genes for Breast Cancer Treatment

- Mien-Chie Hung, Ph.D. and Duen-Hwa Yan, Ph.D.

25. Steps in a Translational Cancer Gene Therapy Trial

- Urs W. von Holzen, M.D. and Stephen G. Swisher, M.D.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)